肾毒宁方联合常规西药治疗慢性肾衰竭3~4 期气虚血瘀证临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R692.5

基金项目:

浙江省中医药科技计划项目(2021ZB314)


Clinical Study on Shenduning Prescription Combined with Conventional Western Medicine for Stage 3-4 Chronic Renal Failure with Qi Deficiency and Blood Stasis Syndrome
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察肾毒宁方联合常规西药对慢性肾衰竭3~4 期气虚血瘀证患者肾功能、炎性因子及中医证候积分的影响。方法:选取120 例慢性肾衰竭3~4 期气虚血瘀证患者,按随机数字表法分为观察组和对照组各60 例。对照组予以常规西药治疗,观察组在对照组基础上加服肾毒宁方。比较2 组中医证候积分、肾功能、免疫功能及炎症因子水平。结果:2 组治疗后尿素氮(BUN)、肌酐(SCr)、尿酸(UA) 较治疗前降低,内生肌酐清除率(CCr) 较治疗前增高(P<0.05);观察组治疗后BUN、SCr、UA 低于对照组,CCr 高于对照组(P<0.05)。2 组治疗后CD4+、CD4+/CD8+较治疗前升高,CD8+较治疗前降低(P<0.05);且观察组CD4+、CD4+/CD8+高于对照组,CD8+低于对照组(P<0.05)。治疗后,观察组免疫球蛋白(IgM、IgG、IgA) 水平均高于对照组(P<0.05)。2 组治疗后C-反应蛋白(CRP)、肿瘤坏死因子-α(TNF-α)、白细胞介素-6(IL-6) 水平较治疗前降低(P<0.05),且观察组降低程度高于对照组(P<0.05)。结论:肾毒宁方联合常规西药可有效改善慢性肾衰竭3~4 期气虚血瘀证患者肾功能和临床症状,提高免疫力,降低炎症反应。

    Abstract:

    Abstract: Objective: To observe the effect of Shenduning Prescription combined with conventional western medicine on the kidney function,inflammatory factors and Chinese medicine syndrome scores in patients with stage 3-4 chronic renal failure with qi deficiency and blood stasis syndrome. Methods:A total of 120 patients with stage 3-4 chronic renal failure with qi deficiency and blood stasis syndrome were selected and divided into the observation group and the control group according to the random number table method,with 60 cases in each group. The control group was treated with conventional western medicine, and the observation group was treated with Shenduning Prescription based on the treatment of the control group. The Chinese medicine syndrome scores, kidney function, immune function and levels of inflammatory factors were compared between the two groups. Results: After treatment, the levels of blood urea nitrogen(BUN),serum creatinine(SCr) and uric acid(UA) were decreased,and the endogenous creatinine clearance rates(CCr) were increased in the two groups(P<0.05). After treatment, the levels of BUN,SCr and UA in the observation group were lower and the CCr was higher than those in the control group(P<0.05). After treatment,the levels of CD4+ and CD4+/CD8+ in the two groups were increased when compared with those before treatment, and the levels of CD8 + were decreased(P<0.05); the levels of CD4+ and CD4+/CD8+ in the observation group were higher and the CD8+ level was lower than those in the control group(P<0.05). After treatment, the levels of immunoglobulin(IgM, IgG, IgA) in the observation group were higher than those in the control group(P<0.05). The levels of C-reactive protein(CRP),tumor necrosis factor-α(TNF-α) and interleukin-6(IL-6) in the two groups after treatment were decreased when compared with those before treatment(P<0.05),and the degree of reduction in the observation group was higher than that in the control group(P<0.05). Conclusion: The therapy of Shenduning Prescription combined with conventional western medicine has effects in improving the kidney function and clinical symptoms,improving immunity and reducing inflammation in patients with stage 3-4 chronic renal failure with qi deficiency and blood stasis syndrome.

    参考文献
    相似文献
    引证文献
引用本文

周华虹,董艺,成栋,傅晓骏.肾毒宁方联合常规西药治疗慢性肾衰竭3~4 期气虚血瘀证临床研究[J].新中医,2022,54(21):101-104

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2022-11-15
  • 出版日期:
文章二维码